Kevin Combs

EVP Pharmaceuticals

Mr. Combs joined PBM Capital in 2011, assuming the role of Executive Vice President of Pharmaceuticals. Prior to joining PBM, Mr. Combs held various executive level positions during his 23 years in the pharmaceutical industry and has direct pharmaceutical experience in Sales, Marketing, Business Development, Operations, Executive Management, Trade/Distribution, and Managed Markets.

From 2008-2011, Mr. Combs built from the ground up, the regional and national sales groups’ new vaccine salesforce for Novartis Vaccines.

From 2006-2008 he was with MedImmun and built from the ground up a United States salesforce for FluMist, exceeding goals by 172% and 114%.

From 2002-2006, Mr. Combs was C.O.O of Vatring and ran daily operations in the United States and Canada, creating 30% sales growth, implementing a sales force for Lanoxin in Canada and completing an acquisition of Worldwide rights for Cycloset (FDA approved product for T2D currently being promoted in the US by Santarus).

From 1989-2002, Mr. Combs was a field rep, hospital rep, and managed care rep for Virginia. He also worked in Trade and distribution and marketing (Timentin/Bactroban - managed $10M operating budget and increased sales over 25%). Mr. Combs was the Executive Director for Vaccines Mid Atlantic, which lead sales for the region in US (20 regions total).

Mr. Combs graduated Cum Laude from West Virginia University with a B.S. in Exercise Physiology.

	Professionals Overview Paul Manning Sean Stalfort Kevin Combs Angelo LoMascolo Chris Reebals Cainon Coates Trevor Seret		Kevin Combs EVP Pharmaceuticals Mr. Combs joined PBM Capital in 2011, assuming the role of Executive Vice President of Pharmaceuticals. Prior to joining PBM, Mr. Combs held various executive level positions during his 23 years in the pharmaceutical industry and has direct pharmaceutical experience in Sales, Marketing, Business Development, Operations, Executive Management, Trade/Distribution, and Managed Markets. From 2008-2011, Mr. Combs built from the ground up, the regional and national sales groups’ new vaccine salesforce for Novartis Vaccines. From 2006-2008 he was with MedImmun and built from the ground up a United States salesforce for FluMist, exceeding goals by 172% and 114%. From 2002-2006, Mr. Combs was C.O.O of Vatring and ran daily operations in the United States and Canada, creating 30% sales growth, implementing a sales force for Lanoxin in Canada and completing an acquisition of Worldwide rights for Cycloset (FDA approved product for T2D currently being promoted in the US by Santarus). From 1989-2002, Mr. Combs was a field rep, hospital rep, and managed care rep for Virginia. He also worked in Trade and distribution and marketing (Timentin/Bactroban - managed $10M operating budget and increased sales over 25%). Mr. Combs was the Executive Director for Vaccines Mid Atlantic, which lead sales for the region in US (20 regions total). Mr. Combs graduated Cum Laude from West Virginia University with a B.S. in Exercise Physiology.